Privia Health (PRVA) Insider Shawn Sells 63,212 Shares
Morris Matthew Shawn sold 63,212 shares of Privia Health Group for about $1.6 million on June 29, 2026.
Reviewed by automated data checks against the source filing. How we make and check alerts
Morris Matthew Shawn sold 63,212 shares of Privia Health Group, Inc. ($PRVA) on June 29, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $PRVA is up 6.4% after 1 week, down 5.6% after 1 month and down 11.9% to date (from the $25.55 close on Jun 29, 2026).
PRVA
Privia Health Group, Inc.
Key Points
- Morris Matthew Shawn sold 63,212 shares of Privia Health Group, valued at about $1.6 million, on June 29, 2026.
- Just days before this sale, Shawn purchased 88,110 shares at $2.00 each, signaling significant insider activity.
- Privia Health has a strong analyst consensus of 'strong buy' with a mean price target of $31.67, reflecting positive sentiment despite recent trading fluctuations.
Get $PRVA trade alerts by text
We text you when insiders, Congress or big funds trade $PRVA. Free.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Privia Health Group, Inc. alert may contain errors. Disclosures
Insider Buying and Selling at Privia Health Group, Inc.
Morris Matthew Shawn sold 63,212 shares of Privia Health Group, Inc. (NASDAQ: PRVA) on June 29, 2026. This transaction is valued at approximately $1.6 million, based on the recent trading price of $25.73. The sale reflects a notable amount of insider trading activity in the healthcare sector.
What Changed in Shawn's Position
Shawn's sale reduced his holdings significantly, moving from 88,110 shares acquired just days earlier to a remaining stake of 24,898 shares. This sale indicates a change in Shawn's investment strategy following his previous purchase, which highlighted his confidence in the company at a much lower price of $2.00 per share.
Stock Performance and Market Context
Privia Health Group's stock has seen strong fluctuations, with a 52-week low of $19.42 and a high of $28.82. The stock's recent price of $25.73 shows it is currently above its 50-day moving average of $22.63. Given the significant trading activity and insider transactions, investors may closely monitor how these dynamics impact the stock's future performance.
Recent Earnings
In its last earnings report, Privia Health Group posted revenue of approximately $2.36 billion, reflecting a revenue growth of 21.4%. The company has a net margin of 1.19% and an EPS of $0.22. The next earnings report is scheduled for November 5, 2026, which may provide additional insights into the company's ongoing performance and strategy.
Insider Buying and Selling at Privia Health Group, Inc.
Before the sale, Morris Matthew Shawn had shown significant confidence in the company by purchasing 88,110 shares on June 26, 2026, at a price of $2.00 each. This was not the only insider activity; David Mountcastle, the CFO, also sold 17,196 shares in a planned transaction around the same time for approximately $432,995. These activities contribute to a complex picture of insider sentiment at Privia Health Group.
Looking Ahead for Privia Health
As the company approaches its next earnings report in November, market watchers will be keen to see how recent insider activity aligns with overall performance. The sizeable sale by Shawn, coming on the heels of his earlier purchase, raises questions about the future direction of his holdings and the company as a whole. Investors should remember that insider trading reports reflect past actions and may not represent current positions. Further developments in the stock’s performance will be interesting to follow.
Related Filing Alerts
Source: Morris Matthew Shawn's Form 4 filing on $PRVA (Jun 29, 2026). Find the original filing: PRVA Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts